Peptides are here!
eptides are moving forward, and iBiome is ready.
iBiome is positioned to help patients navigate Peptides safely and intelligently.
Across July 23–24, the FDA’s advisory committee, there was a complex, mixed outcome, with advisers supporting compounding access for six of seven peptides, while FDA career staff still recommended against inclusion due to limited human data and safety concerns.
Because nothing is final yet, and because the science is still evolving, peptides only make sense when your terrain is ready and your physiology can actually use the signal.
At iBiome, we evaluate your whole physiology first, recovery patterns, inflammation tone, gut stability, sleep architecture, metabolic rhythm, and stress physiology, to determine whether peptide therapy aligns with your biology and your goals.
The July 23–24 PCAC meeting considered whether specific bulk drug substances should be added to the 503A Bulks List, not whether “peptide therapy” is effective in general.
Each Peptide was judged for specific use.
BPC-157: ulcerative colitis
KPV: wound healing and inflammatory conditions
TB-500: wound healing
MOTS-c: obesity and osteoporosis
Emideltide/DSIP: opioid withdrawal, chronic insomnia, narcolepsy
Semax: cerebral ischemia, migraine, trigeminal neuralgia
Epitalon: insomnia
The panel was (in some votes) nearly split 50/50. These are recommendations, not final rules. The complete regulatory process can take up to 2 years.
Day 1 Votes (July 23):
BPC‑157 — passed 8–6 (1 abstention)
KPV — passed 8–6 (1 abstention)
TB‑500 — passed 8–6 (1 abstention)
MOTS‑c — passed 7–5 (2 abstentions)
Day 2 Votes (July 24):
Semax — passed 8–5 (1 abstention)
Epitalon — passed 7–5 (1 abstention)
Emideltide (DSIP) — rejected 6–7 (1 abstention)
This means 6 peptides received a positive advisory vote, and 1 was rejected. There was open disagreement, FDA staff repeatedly emphasized:
scant human safety data
inadequate clinical trials
concerns about effectiveness
Meanwhile, the advisory panel, some with industry ties (thats important to note),voted in favor of compounding access for most peptides.
This created a split outcome: FDA staff = no Advisory panel = mostly yes
At iBiome, we don't view Peptides as trends, they are signaling molecules.
Short chains of amino acids that act like biological messages inside the body.
They don’t “fix” things.
They don’t “heal” things.
They don’t “force” outcomes.
They signal.
They tell cells:
what to repair
what to calm
what to activate
what to regulate
what to build
what to restore
Peptides are communication tools, not magic molecules.
A signal only works when:
the right cell can hear it
the right pathway is open
the terrain is stable
the physiology is ready
the timing is appropriate
the mechanism matches the need
This is why iBiome does not treat peptides as standalone therapies. We use peptides as precision signals inside a whole‑person plan.
The FDA Meeting outcome was complex:
FDA scientists: recommended NO peptides
Advisory committee: recommended YES on 6 peptides
One peptide (DSIP) was rejected
Nothing is fully FDA approved yet
FDA still has to decide whether to begin rulemaking
Rulemaking takes months
The long term and human trials science remains thin
Anecdotal evidence remains strong
The regulatory environment is politically charged
Clinicians must navigate uncertainty with caution
What the FDA Vote Does Not Tell Us:
which patient should receive a peptide
which dose is appropriate
how long therapy should continue
which formulation or pharmacy is reliable
what underlying biology must be corrected first
whether a patient’s risk profile outweighs the potential benefit
Those are clinical questions. Clinical application matters.
Where you get them, how they are used in your plan of care.
iBiome Tip: There are some things that WELLNESS has missed the plot on, if you are taking outsources peptides, make sure you are sourcing your peptides from practices that use a clinical model, not a business model.
The new rules support safer, smarter peptide integration.
iBiome uses peptides only when the signal matches the physiology. Because peptides are signals, they only work when:
the right pathway is open
the terrain is stable
the physiology needs that signal
the timing is appropriate
the mechanism matches the goal
This is why iBiome does not prescribe peptides in isolation. We integrate peptides only after evaluating:
metabolic architecture
mitochondrial efficiency
inflammatory load
gut terrain
neurological rhythm
sleep architecture
recovery patterns
hormonal context
long‑term goals
Peptides are one tool inside a medically‑supervised plan, never the plan itself. When we put you on a peptide, its after all of the above has been addressed.
iBiome Peptide Priming
Peptides do not override your biology, they amplify what your body is already trying to do.
Peptides are one component of regenerative medicine. They are not a substitute for the physiology required to respond to them.
Think of this as priming your physiology so peptide therapy (if indicated later) is safer, smoother, and more effective.
Start here:
Add one “fiber anchor” to your next meal.
Fiber modulates post‑meal glucose, reduces inflammatory noise, and stabilizes gut‑brain signaling, all of which improve peptide responsiveness.
iBiome Tip: Add chia, or organic whole flax seeds
iBiome Tips: Sprinkle Chia on your salad, only use whole flax seeds and store in the fridge.
Do one “glymphatic cue” before bed.
The glymphatic system clears metabolic waste during sleep.
Peptide signaling is stronger when glymphatic flow is supported.
iBiome Tip: dim lights, create a cooler room, or 5 minutes of gentle stretching 3 hours prior to bedtime
iBiome Tip: Change your lightbulbs to incandescent
Get the LED lights out of your home!
Add one “mitochondrial spark” moment today.
Mitochondria determine how cells respond to peptide signals. Small bursts of movement improve mitochondrial readiness.
iBiome Tip: Do 20–30 seconds of gentle movement: stairs, marching, stretching, posture reset, at any point in your day!
Create one “anti‑noise” moment for your gut.
Gut inflammation blunts peptide signaling. I never use peptides on an inflamed gut!
Reducing even one trigger improves receptor sensitivity.
iBiome Tip: Swap one gut irritant (fried food, heavy processed item) for a calmer, cooler option
Add one “thermal shift” today.
Temperature variation activates metabolic and mitochondrial pathways that peptides also influence.
iBiome Tip: Use one thermal shift: warm shower → cool rinse, or step outside briefly.
Take a 10‑minute “glucose disposal walk” after your next meal.
iBiome Tip: Post‑meal movement improves mitochondrial signaling, glucose handling, and AMPK activation, the same pathways peptides like MOTS‑c support.
iBiome Tip: Walk 10 minutes after your next meal.
